A team at Bayer HealthCare in Germany last year reported4 that only about 25% of published preclinical studies could be validated to the point at which projects could continue.
Misinterpreted
所有跟帖:
•
拜耳是另外一个。Amgen只能重复大约 10%,而且他们都联系了原作者讨论实验条件的。
-viewfinder-
♀
(764 bytes)
()
10/02/2014 postreply
06:41:58
•
Wrong interpretation: they said "could be validated to the point
-26484915-
♂
(40 bytes)
()
10/02/2014 postreply
06:44:13
•
说的不是拜耳而是Amgen. “ were able to reproduce findings in only 11% of
-viewfinder-
♀
(190 bytes)
()
10/02/2014 postreply
06:48:56
•
Amgen 是这样定义 non-reproduced
-26484915-
♂
(369 bytes)
()
10/02/2014 postreply
07:32:03